Chat with an Expert

BIO

WNT pathway activator; Inhibits GSK3

More Views

From: 54 USD

Options

* Required Fields

Catalog # (Select a product)
WNT pathway activator; Inhibits GSK3
From: 54 USD

Overview

BIO is an indirubin compound that is cell-permeable and is a selective and potent reversible inhibitor of GSK3α and GSK3β (IC₅₀ = 5 nM) and functions as a WNT activator.

REPROGRAMMING
· Enhances reprogramming of mouse fibroblasts, neural stem cells, and thymocytes to induced pluripotent stem (iPS) cells (Lluis et al.).

MAINTENANCE AND SELF-RENEWAL
· Maintains self-renewal of mouse embryonic stem (ES) cells in the absence of LIF (Sato et al.).
· Maintains self-renewal of human ES cells in unconditioned medium through a SMAD 2/3 dependent mechanism (James et al., Sato et al.).
· Induces proliferation of neonatal and adult rat cardiomyocytes (Tseng et al.).

DIFFERENTIATION
· Promotes differentiation of cardiomyocytes from human ES and iPS cells (Lian et al.).
Alternative Names:
GSK 3 IX; MLS 2052; 6-Bromoindirubin-3'-oxime
CAS Number:
667463-62-9
Chemical Formula:
C₁₆H₁₀BrN₃O₂
Molecular Weight:
356.2 g/mol
Purity:
≥ 98%
Pathway:
WNT
Target:
GSK3

Scientific Resources

Product Documentation

Document Type
Product Name
Catalog #
Lot #
Language

Educational Materials

(5)

Product Applications

This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.

Data and Publications

Publications

(2)
Proceedings of the National Academy of Sciences of the United States of America 2012 JUL

Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling.

Lian X et al.

Abstract

Human pluripotent stem cells (hPSCs) offer the potential to generate large numbers of functional cardiomyocytes from clonal and patient-specific cell sources. Here we show that temporal modulation of Wnt signaling is both essential and sufficient for efficient cardiac induction in hPSCs under defined, growth factor-free conditions. shRNA knockdown of β-catenin during the initial stage of hPSC differentiation fully blocked cardiomyocyte specification, whereas glycogen synthase kinase 3 inhibition at this point enhanced cardiomyocyte generation. Furthermore, sequential treatment of hPSCs with glycogen synthase kinase 3 inhibitors followed by inducible expression of β-catenin shRNA or chemical inhibitors of Wnt signaling produced a high yield of virtually (up to 98%) pure functional human cardiomyocytes from multiple hPSC lines. The robust ability to generate functional cardiomyocytes under defined, growth factor-free conditions solely by genetic or chemically mediated manipulation of a single developmental pathway should facilitate scalable production of cardiac cells suitable for research and regenerative applications.
Chemistry & biology 2003 DEC

GSK-3-selective inhibitors derived from Tyrian purple indirubins.

Meijer L et al.

Abstract

Gastropod mollusks have been used for over 2500 years to produce the Tyrian purple" dye made famous by the Phoenicians. This dye is constituted of mixed bromine-substituted indigo and indirubin isomers. Among these�
STEMCELL TECHNOLOGIES INC.’S QUALITY MANAGEMENT SYSTEM IS CERTIFIED TO ISO 13485. PRODUCTS ARE FOR RESEARCH USE ONLY AND NOT INTENDED FOR HUMAN OR ANIMAL DIAGNOSTIC OR THERAPEUTIC USES UNLESS OTHERWISE STATED.